{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:13:03Z","timestamp":1771258383765,"version":"3.50.1"},"reference-count":31,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1536\/ihj.14-250","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T22:05:20Z","timestamp":1424988320000},"page":"239-244","source":"Crossref","is-referenced-by-count":11,"title":["Fulminant Type 1 Diabetes Mellitus and Fulminant Viral Myocarditis"],"prefix":"10.1536","volume":"56","author":[{"given":"Nobumasa","family":"Ohara","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Nagaoka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Nagaoka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohiko","family":"Kuwano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagaoka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Ebe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagaoka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagaoka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneo","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nagaoka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagaoka Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifusa","family":"Aizawa","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Tachikawa Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyuzi","family":"Kamoi","sequence":"additional","affiliation":[{"name":"Department of Center of Diabetes, Endocrinology and Metabolism, Joetsu General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version. Circ J 2011; 75: 734-43.","DOI":"10.1253\/circj.CJ-88-0008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet 2012; 379: 738-47. (Review)","DOI":"10.1016\/S0140-6736(11)60648-X"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Otsu F, Otake M, Hayakawa H, Toyoda T, Yokota M. A case of parainfluenza viral myocarditis showing various kinds of conduction disturbances (author\u2019s transl). Nihon Naika Gakkai Zasshi 1978; 67: 510-4. (Japanese)","DOI":"10.2169\/naika.67.510"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wilks D, Burns SM. Myopericarditis associated with parainfluenza virus type 3 infection. Eur J Clin Microbiol Infect Dis 1998; 17: 363-5.","DOI":"10.1007\/BF01709464"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gupta S, Markham DW, Drazner MH, Mammen PP. Fulminant myocarditis. Nat Clin Pract Cardiovasc Med 2008; 5: 693-706. (Review)","DOI":"10.1038\/ncpcardio1331"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kawasaki E, Matsuura N, Eguchi K. Type 1 diabetes in Japan. Diabetologia 2006; 49: 828-36. (Review)","DOI":"10.1007\/s00125-006-0213-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kawasaki E, Maruyama T, Imagawa A, <i>et al<\/i>. Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus. J Diabetes Investig 2014; 5: 115-8.","DOI":"10.1111\/jdi.12119"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 2000; 342: 301-7.","DOI":"10.1056\/NEJM200002033420501"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Imagawa A, Hanafusa T. Fulminant type 1 diabetes mellitus. Endocr J 2006; 53: 577-84. (Review)","DOI":"10.1507\/endocrj.KR-72"},{"key":"10","unstructured":"10. Hanafusa T, Imagawa A, Iwahashi H, <i>et al<\/i>. Report of the Japan Diabetes Society\u2019s Committee on research on fulminant type 1 diabetes mellitus: analysis of antiviral antibodies at disease onset. J Japan Diabetes Soc 2008; 51: 531-6. (Japanese)"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mokuno T, Sawai Y, Oda N, <i>et al<\/i>. A case of myocarditis associated with IDDM. Diabetes Care 1996; 19: 374-8.","DOI":"10.2337\/diacare.19.4.374"},{"key":"12","unstructured":"12. Yamada T, Kato Y, Yambe Y, <i>et al<\/i>. A case of fulminant type 1 diabetes mellitus with pericarditis and myocarditis manifested by symptoms of conjunctivitis \u2013 a case of fulminant type 1 diabetes mellitus suspected viral infection. J Japan Diabetes Soc 2010; 53: 180-6. (Japanese)"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hiramatsu S, Komori K, Mori E, Ogo A, Maruyama S, Kato S. A case of fulminant type 1 diabetes mellitus accompanied by myocarditis. Endocr J 2011; 58: 553-7.","DOI":"10.1507\/endocrj.K11E-007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Makino K, Nishimae I, Suzuki N, <i>et al<\/i>. Myocarditis with fulminant type 1 diabetes mellitus diagnosed by cardiovascular magnetic resonance imaging: a case report. BMC Res Notes 2013; 6: 347.","DOI":"10.1186\/1756-0500-6-347"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mori Y, Nishikawa Y, Kobayashi F, Hiramatsu K. Clinical status and outcome of Japanese heart failure patients with reduced or preserved ejection fraction treated with carvedilol. Int Heart J 2013; 54: 15-22.","DOI":"10.1536\/ihj.54.15"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Dinarello CA. Historical insights into cytokines. Eur J Immunol 2007; 37: S34-45. (Review)","DOI":"10.1002\/eji.200737772"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Imagawa A, Hanafusa T, Awata T, <i>et al<\/i>. Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-Onset Type 1 Diabetes Mellitus: New diagnostic criteria for fulminant type 1 diabetes mellitus (2012). J Diabetes Investig 2012; 3: 536-9.","DOI":"10.1111\/jdi.12024"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kawabata Y, Ikegami H, Awata T, <i>et al<\/i>. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia 2009; 52: 2513-21.","DOI":"10.1007\/s00125-009-1539-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Thygesen K, Alpert JS, White HD; Joint ESC\/ACCF\/AHA\/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007; 28: 2525-38.","DOI":"10.1093\/eurheartj\/ehm355"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wang K, Asinger RW, Marriott HJ. ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 2003; 349: 2128-35. (Review)","DOI":"10.1056\/NEJMra022580"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Akashi YJ, Goldstein DS, Barbaro G, Ueyama T. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation 2008; 118: 2754-62. (Review)","DOI":"10.1161\/CIRCULATIONAHA.108.767012"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Henrickson KJ. Parainfluenza viruses. Clin Microbiol Rev 2003; 16: 242-64. (Review)","DOI":"10.1128\/CMR.16.2.242-264.2003"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994; 72: 561-6.","DOI":"10.1136\/hrt.72.6.561"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nishii M, Inomata T, Takehana H, <i>et al<\/i>. Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol 2004; 44: 1292-7.","DOI":"10.1016\/j.jacc.2004.01.055"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Fuse K, Kodama M, Okura Y, <i>et al<\/i>. Short-term prognostic value of initial serum levels of interleukin-10 in patients with acute myocarditis. Eur J Heart Fail 2005; 7: 109-12.","DOI":"10.1016\/j.ejheart.2004.03.006"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Takahashi T, Yu F, Saegusa S, <i>et al<\/i>. Impaired expression of cardiac adiponectin in leptin-deficient mice with viral myocarditis. Int Heart J 2006; 47: 107-23.","DOI":"10.1536\/ihj.47.107"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Nishio R, Matsumori A, Shioi T, Ishida H, Sasayama S. Treatment of experimental viral myocarditis with interleukin-10. Circulation 1999; 100: 1102-8.","DOI":"10.1161\/01.CIR.100.10.1102"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kanda T, McManus JE, Nagai R, <i>et al<\/i>. Modification of viral myocarditis in mice by interleukin-6. Circ Res 1996; 78: 848-56.","DOI":"10.1161\/01.RES.78.5.848"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Mann DL. Interleukin-6 and viral myocarditis: the Yin-Yang of cardiac innate immune responses. J Mol Cell Cardiol 2001; 33: 1551-3. (Review)","DOI":"10.1006\/jmcc.2001.1432"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Tanaka S, Aida K, Nishida Y, Kobayashi T. Pathophysiological mechanisms involving aggressive islet cell destruction in fulminant type 1 diabetes. Endocr J 2013; 60: 837-45. (Review)","DOI":"10.1507\/endocrj.EJ13-0222"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Oshima K, Morishita Y, Hinohara H, Hayashi Y, Tajima Y, Kunimoto F. Factors for weaning from a percutaneous cardiopulmonary support system (PCPS) in patients with severe cardiac failure: a comparative study in weaned and nonweaned patients. Int Heart J 2006; 47: 575-84.","DOI":"10.1536\/ihj.47.575"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T06:22:31Z","timestamp":1498198951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/56\/2\/56_14-250\/_article"}},"subtitle":["A Case Report and Literature Review"],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.14-250","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}